Efficacy and safety of the Neuroform Atlas stent for bifurcation type unruptured cerebral aneurysms: Comparison of single versus Y stents with propensity score matching

IF 3 3区 医学 Q2 CLINICAL NEUROLOGY
Rintaro Tachi , Michiyasu Fuga , Toshihiro Ishibashi , Kazufumi Horiuchi , Akihiko Teshigawara , Ken Aoki , Issei Kan , Toshihide Tanaka , Yuichi Murayama
{"title":"Efficacy and safety of the Neuroform Atlas stent for bifurcation type unruptured cerebral aneurysms: Comparison of single versus Y stents with propensity score matching","authors":"Rintaro Tachi ,&nbsp;Michiyasu Fuga ,&nbsp;Toshihiro Ishibashi ,&nbsp;Kazufumi Horiuchi ,&nbsp;Akihiko Teshigawara ,&nbsp;Ken Aoki ,&nbsp;Issei Kan ,&nbsp;Toshihide Tanaka ,&nbsp;Yuichi Murayama","doi":"10.1016/j.neurad.2025.101369","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Purpose</h3><div>Y-stent-assisted coiling (Y-SAC) using two stents can provide adequate coverage of the aneurysm neck even in wide-neck bifurcation-type aneurysms, but whether it is more effective and safer than single-stent-assisted coiling (S-SAC) remains unclear. The purpose of this study was to investigate the efficacy and safety of Y-SAC with the Neuroform Atlas stent for bifurcation-type unruptured cerebral aneurysms (UCAs).</div></div><div><h3>Materials and Methods</h3><div>A total of 186 bifurcation-type UCAs treated with the Neuroform Atlas stent were retrospectively reviewed. The aneurysms were divided into Y-SAC and S-SAC groups. Angiographic occlusion status and complication rates were analyzed using 1:2 propensity score matching.</div></div><div><h3>Results</h3><div>Of the 186 UCAs, 17 (9.1 %) were treated by Y-SAC. Propensity score matching was successful for 14 UCAs in the Y-SAC group and 28 UCAs in the S-SAC group. After propensity score matching, the Y-SAC group had a higher rate of complete occlusion immediately after treatment (71.4 % vs. 32.1 %, <em>P</em> = 0.023), a significantly higher volume embolization ratio (33.3 % [IQR: 30.4, 38.5] vs. 28.9 % [IQR: 24.1, 32.4], <em>P</em> = 0.03), and higher device and implant costs ($11,335 [IQR: $10,427, $13,894] vs. $9592 [IQR: $8211, $10,959], <em>P</em> = 0.002) compared to the S-SAC group. However, the rate of complete occlusion at one year (78.6 % vs. 64.3 %, <em>P</em> = 0.485) and the recanalization rate (14.3 % vs. 3.6 %, <em>P</em> = 0.254) did not differ significantly between the two groups. No significant differences in the incidences of any complications were found between the two groups.</div></div><div><h3>Conclusions</h3><div>Y-SAC did not improve the complete occlusion rate at one year or reduce the risk of recanalization compared with S-SAC. Given its procedural simplicity and cost-effectiveness, S-SAC may be the preferred strategy for embolizing bifurcation-type UCAs.</div></div>","PeriodicalId":50115,"journal":{"name":"Journal of Neuroradiology","volume":"52 5","pages":"Article 101369"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuroradiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0150986125001270","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Purpose

Y-stent-assisted coiling (Y-SAC) using two stents can provide adequate coverage of the aneurysm neck even in wide-neck bifurcation-type aneurysms, but whether it is more effective and safer than single-stent-assisted coiling (S-SAC) remains unclear. The purpose of this study was to investigate the efficacy and safety of Y-SAC with the Neuroform Atlas stent for bifurcation-type unruptured cerebral aneurysms (UCAs).

Materials and Methods

A total of 186 bifurcation-type UCAs treated with the Neuroform Atlas stent were retrospectively reviewed. The aneurysms were divided into Y-SAC and S-SAC groups. Angiographic occlusion status and complication rates were analyzed using 1:2 propensity score matching.

Results

Of the 186 UCAs, 17 (9.1 %) were treated by Y-SAC. Propensity score matching was successful for 14 UCAs in the Y-SAC group and 28 UCAs in the S-SAC group. After propensity score matching, the Y-SAC group had a higher rate of complete occlusion immediately after treatment (71.4 % vs. 32.1 %, P = 0.023), a significantly higher volume embolization ratio (33.3 % [IQR: 30.4, 38.5] vs. 28.9 % [IQR: 24.1, 32.4], P = 0.03), and higher device and implant costs ($11,335 [IQR: $10,427, $13,894] vs. $9592 [IQR: $8211, $10,959], P = 0.002) compared to the S-SAC group. However, the rate of complete occlusion at one year (78.6 % vs. 64.3 %, P = 0.485) and the recanalization rate (14.3 % vs. 3.6 %, P = 0.254) did not differ significantly between the two groups. No significant differences in the incidences of any complications were found between the two groups.

Conclusions

Y-SAC did not improve the complete occlusion rate at one year or reduce the risk of recanalization compared with S-SAC. Given its procedural simplicity and cost-effectiveness, S-SAC may be the preferred strategy for embolizing bifurcation-type UCAs.

Abstract Image

神经形态Atlas支架治疗分叉型未破裂脑动脉瘤的疗效和安全性:单支架与Y支架倾向评分匹配的比较
背景与目的:使用两个支架的y -支架辅助卷绕(Y-SAC)即使在宽颈分岔型动脉瘤中也能提供足够的动脉瘤颈部覆盖,但是否比单支架辅助卷绕(S-SAC)更有效和安全尚不清楚。本研究的目的是探讨Y-SAC联合神经形态Atlas支架治疗分叉型未破裂脑动脉瘤(UCAs)的疗效和安全性。材料与方法:回顾性分析应用Neuroform Atlas支架治疗的186例分叉型uca。动脉瘤分为Y-SAC组和S-SAC组。采用1:2倾向评分匹配分析血管造影闭塞状况和并发症发生率。结果:186例uca中,Y-SAC治疗17例(9.1%)。Y-SAC组14例uca和S-SAC组28例uca的倾向评分匹配成功。倾向评分匹配后,Y-SAC组治疗后立即完全闭塞率较高(71.4%比32.1%,P=0.023),体积栓塞率显著高于S-SAC组(33.3% [IQR: 30.4, 38.5]比28.9% [IQR: 24.1, 32.4], P=0.03),器械和种植体费用较高(11,335美元[IQR: 10,427美元,13,894美元]比9,592美元[IQR: 8,211美元,10,959美元],P=0.002)。然而,两组1年完全闭塞率(78.6% vs. 64.3%, P=0.485)和再通率(14.3% vs. 3.6%, P=0.254)无显著差异。两组患者并发症发生率无显著差异。结论:与S-SAC相比,Y-SAC不能提高1年完全闭塞率,也不能降低再通的风险。鉴于其程序简单和成本效益,S-SAC可能是栓塞分叉型uca的首选策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neuroradiology
Journal of Neuroradiology 医学-核医学
CiteScore
6.10
自引率
5.70%
发文量
142
审稿时长
6-12 weeks
期刊介绍: The Journal of Neuroradiology is a peer-reviewed journal, publishing worldwide clinical and basic research in the field of diagnostic and Interventional neuroradiology, translational and molecular neuroimaging, and artificial intelligence in neuroradiology. The Journal of Neuroradiology considers for publication articles, reviews, technical notes and letters to the editors (correspondence section), provided that the methodology and scientific content are of high quality, and that the results will have substantial clinical impact and/or physiological importance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信